No images? Click here
Thursday, 9 March 2023
MEDIA ADVISORY
Integrating Research into Outbreaks: How can we prepare for the next Marburg outbreak?
10 March 2023 - 1400 CET
The WHO R&D Blueprint is organizing a consultation with the MARVAC partners and focal points from at-risk countries to discuss Marburg vaccine and therapeutic candidates and integrating research during an outbreak.
Preliminary Agenda
1- Outbreak sit rep including diagnostics and epidemiology
2- Review of core trial protocols for vaccines and therapeutics
3- Panel discussion from at-risk country focal points
The MARVAC includes leaders in the field of vaccine research and development, working together to develop vaccines against this infectious disease threat.
This is an open webinar. Registration link for non-MARVAC members: https://who-e.zoom.us/webinar/register/WN_ETAht7eETMStDmUah5mDaA
Resources
- Marburg virus disease (who.int)
- Press release: Equatorial Guinea confirms first-ever Marburg virus disease outbreak https://www.afro.who.int/countries/equatorial-guinea/news/equatorial-guinea-confirms-first-ever-marburg-virus-disease-outbreak
- Landscape of candidate vaccines for Marburg virus disease https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010805
- Current progress, challenges, and future directions for Marburg virus disease vaccines https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679315/
- R&D Blueprint agenda for filovirus research and monitoring https://www.who.int/publications/m/item/a-who-strategic-research-agenda-for-filovirus-research-and-monitoring-----(who-afirm)
- R&D Blueprint for Ebolavirus and Marburg https://www.who.int/teams/blueprint/ebolavirus
- Marburg virus disease factsheet https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease
Media contacts:
You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to WHO Media Team
